PAG
ADMA icon

Private Advisor Group’s ADMA Biologics ADMA Stock Holding History

Private Advisor Group’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,241
Closed -$205K – 2567
2025
Q2 		$205K Buy
+11,241
New +$229K ﹤0.01% 2222
2022
Q2 		– Sell
-10,000
Closed -$18K – 2113
2022
Q1 		$18K Buy
+10,000
New +$15.6K ﹤0.01% 2069
2020
Q3 		– Sell
-1,950
Closed -$6K – 1578
2020
Q2 		$6K Sell
1,950
-14,647
-88% -$42.1K ﹤0.01% 3133
2020
Q1 		$48K Buy
16,597
+78
+0.5% +$270 ﹤0.01% 1364
2019
Q4 		$66K Buy
16,519
+19
+0.1% +$83 ﹤0.01% 1576
2019
Q3 		$74K Sell
16,500
-1,045
-6% -$4.37K ﹤0.01% 1596
2019
Q2 		$67K Buy
17,545
+2,045
+13% +$9.03K ﹤0.01% 1611
2019
Q1 		$59K Hold
15,500
– – ﹤0.01% 1510
2018
Q4 		$35K Buy
15,500
+2,700
+21% +$13.4K ﹤0.01% 1334
2018
Q3 		$79K Sell
12,800
-39,291
-75% -$226K ﹤0.01% 1552
2018
Q2 		$235K Buy
+52,091
New +$260K ﹤0.01% 1104

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Private Advisor Group's ADMA Position: Q3 2025 in Review

Private Advisor Group sold out of ADMA Biologics (ADMA) in Q3 2025, closing a stake of 11,241 shares — an estimated $205K sold.

Private Advisor Group first reported a position in ADMA in Q2 2018 and held it in 11 quarters. The position peaked at $235K in Q2 2018. 365 funds tracked by Wall St. Rank hold ADMA as of Q3 2025.

  • Private Advisor Group reported no remaining ADMA Biologics position as of Q3 2025 after selling out during the quarter.
  • Private Advisor Group sold 11,241 ADMA Biologics shares in Q3 2025, an estimated $205K.
  • Private Advisor Group first reported a position in ADMA Biologics in Q2 2018 and held it in 11 quarters.
  • Private Advisor Group's ADMA Biologics position peaked at $235K in Q2 2018.
  • 365 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2025.

Based on Private Advisor Group's 13F filing for Q3 2025, filed 13 Nov 2025.